ArticleThe World Allergy Organization journal2019

Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America.

Ivan Cherrez-Ojeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.